Inhibition of extracellular matrix-degrading endopeptidases: problems, comments, and hypotheses

Area of Science:

• Biochemistry
• Pharmacology
• Enzymology

Background:

• Extracellular matrix (ECM)-degrading endopeptidases play crucial roles in physiological and pathological processes.
• Inhibitors of these enzymes are being investigated for therapeutic applications.
• Significant hurdles exist in translating potential inhibitors into effective treatments.

Purpose of the Study:

• To critically analyze research on inhibitors of ECM-degrading endopeptidases.
• To identify potential therapeutic agents and assess the obstacles to their clinical use.

Main Methods:

• Literature review and critical analysis of existing research.
• Evaluation of inhibitor characteristics and pathological environment factors.

Main Results:

• A wide array of substances demonstrate potential as inhibitors.
• Obstacles to therapeutic application are multifaceted, stemming from both inhibitor properties and the nature of the pathological environment.
• Chemical modification may overcome inhibitor-specific issues.
• Inherent properties of the disease microenvironment and enzyme mechanisms present more intractable challenges.

Conclusions:

• While numerous compounds show promise, the development of effective therapies targeting ECM-degrading endopeptidases faces significant challenges.
• Solutions may require innovative approaches beyond simple chemical modifications, particularly when dealing with the complex pathological milieu.